BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 9488258)

  • 1. Effect of delayed treatment with recombinant human granulocyte colony-stimulating factor on survival and plasma cytokine levels in a non-neutropenic porcine model of Pseudomonas aeruginosa sepsis.
    Haberstroh J; Wiese K; Geist A; Dursunoglu GB; Gippner-Steppert C; Jochum M; von Specht BU
    Shock; 1998 Feb; 9(2):128-34. PubMed ID: 9488258
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of recombinant human granulocyte colony-stimulating factor on hemodynamic and cytokine response in a porcine model of Pseudomonas sepsis.
    Haberstroh J; Breuer H; Lücke I; Massarrat K; Früh R; Mand U; Hagedorn P; Brunnberg L; von Specht BU
    Shock; 1995 Sep; 4(3):216-24. PubMed ID: 8574758
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Additive effects of human recombinant interleukin-11 and granulocyte colony-stimulating factor in experimental gram-negative sepsis.
    Opal SM; Jhung JW; Keith JC; Goldman SJ; Palardy JE; Parejo NA
    Blood; 1999 May; 93(10):3467-72. PubMed ID: 10233899
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of recombinant human granulocyte colony-stimulating factor administration in normal and experimentally infected newborn rats.
    Iguchi K; Inoue S; Kumar A
    Exp Hematol; 1991 Jun; 19(5):352-8. PubMed ID: 1709109
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human granulocyte colony-stimulating factor may improve outcome attributable to neonatal sepsis complicated by neutropenia.
    Kocherlakota P; La Gamma EF
    Pediatrics; 1997 Jul; 100(1):E6. PubMed ID: 9200380
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardiopulmonary effects of granulocyte colony-stimulating factor in a canine model of bacterial sepsis.
    Eichacker PQ; Waisman Y; Natanson C; Farese A; Hoffman WD; Banks SM; MacVittie TJ
    J Appl Physiol (1985); 1994 Nov; 77(5):2366-73. PubMed ID: 7532649
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of granulocyte colony-stimulating factor on systemic and pulmonary responses to endotoxin in pigs.
    Fink MP; O'Sullivan BP; Menconi MJ; Wollert SP; Wang H; Youssef ME; Bellelsle JM
    J Trauma; 1993 Apr; 34(4):571-7; discussion 577-8. PubMed ID: 7683731
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adjunctive efficacy of granulocyte colony-stimulating factor on treatment of Pseudomonas aeruginosa pneumonia in neutropenic and non-neutropenic hosts.
    Babalola CP; Nightingale CH; Nicolau DP
    J Antimicrob Chemother; 2004 Jun; 53(6):1098-100. PubMed ID: 15128727
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A randomized, double-masked, placebo-controlled trial of recombinant granulocyte colony-stimulating factor administration to preterm infants with the clinical diagnosis of early-onset sepsis.
    Miura E; Procianoy RS; Bittar C; Miura CS; Miura MS; Mello C; Christensen RD
    Pediatrics; 2001 Jan; 107(1):30-5. PubMed ID: 11134430
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of granulocyte colony-stimulating factor on plasma cytokine and cytokine receptor levels and on the in vivo host response to endotoxin in healthy men.
    Pollmächer T; Korth C; Mullington J; Schreiber W; Sauer J; Vedder H; Galanos C; Holsboer F
    Blood; 1996 Feb; 87(3):900-5. PubMed ID: 8562960
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cytokine profile during high-dose rhG-CSF therapy in severe congenital neutropenia.
    Shitara T; Yugami S; Ijima H; Sotomatu M; Kuroume T
    Am J Hematol; 1994 Jan; 45(1):58-62. PubMed ID: 7504401
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A synergistic increase in transplantable peripheral blood stem cells in mice by co-administration of recombinant human interleukin 6 and recombinant human granulocyte colony-stimulating factor.
    Suzuki H; Okano A; Suzuki C; Konishi A; Akiyama Y; Ishibashi T; Ozawa K; Asano S
    Transplantation; 1995 Jun; 59(11):1596-600. PubMed ID: 7539959
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of granulocyte colony-stimulating factor in modifying mortality from Pseudomonas aeruginosa pneumonia after hemorrhage.
    Abraham E; Stevens P
    Crit Care Med; 1992 Aug; 20(8):1127-33. PubMed ID: 1379529
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prophylactic or simultaneous administration of recombinant human granulocyte colony stimulating factor in the treatment of group B streptococcal sepsis in neonatal rats.
    Cairo MS; Mauss D; Kommareddy S; Norris K; van de Ven C; Modanlou H
    Pediatr Res; 1990 Jun; 27(6):612-6. PubMed ID: 1694023
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of recombinant human granulocyte colony-stimulating factor on hematopoiesis in normal cats.
    Fulton R; Gasper PW; Ogilvie GK; Boone TC; Dornsife RE
    Exp Hematol; 1991 Sep; 19(8):759-67. PubMed ID: 1714401
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor have differential effects on neonatal and adult neutrophil survival and function.
    Molloy EJ; O'Neill AJ; Grantham JJ; Sheridan-Pereira M; Fitzpatrick JM; Webb DW; Watson RW
    Pediatr Res; 2005 Jun; 57(6):806-12. PubMed ID: 15718363
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Granulocyte colony-stimulating factor enhances host defenses against bacterial pneumonia following peritonitis in nonneutropenic rats.
    Attalah HL; Azoulay E; Yang K; Lasclos C; Jouault H; Soussy CJ; Guillot T; Brochard L; Brun-Buisson C; Harf A; Delclaux C
    Crit Care Med; 2002 Sep; 30(9):2107-14. PubMed ID: 12352049
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A trial of recombinant human granulocyte colony stimulating factor for the treatment of very low birthweight infants with presumed sepsis and neutropenia.
    Bedford Russell AR; Emmerson AJ; Wilkinson N; Chant T; Sweet DG; Halliday HL; Holland B; Davies EG
    Arch Dis Child Fetal Neonatal Ed; 2001 May; 84(3):F172-6. PubMed ID: 11320043
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Granulocyte colony-stimulating factor prophylaxis improves survival and inflammation in a two-hit model of hemorrhage and sepsis.
    Bauhofer A; Lorenz W; Kohlert F; Torossian A
    Crit Care Med; 2006 Mar; 34(3):778-84. PubMed ID: 16521271
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increase of anti-inflammatory cytokines in patients with esophageal cancer after perioperative treatment with G-CSF.
    Hübel K; Mansmann G; Schäfer H; Oberhäuser F; Diehl V; Engert A
    Cytokine; 2000 Dec; 12(12):1797-800. PubMed ID: 11097751
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.